NCT06836726 2026-01-28
EVO
University Health Network, Toronto
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT05919329 2025-10-24
Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy
OHSU Knight Cancer Institute
Phase 4 Recruiting
NCT07161778 2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2 Completed
NCT05445882 2024-04-02
N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT01540071 2021-05-14
Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer
Io Therapeutics
Phase 2 Completed
NCT02502994 2015-07-20
Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC
Osaka University
Phase 1 Unknown